Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Oct 27 - Nov 1
Unlike RCT populations that are often treatment naive or tightly selected, our cohort reflects a heterogeneous, treatment-experienced real-world population
HS-10535, a preclinical candidate targeting incretin biology, may offer cardiometabolic benefits beyond weight management
Levocarnitine has isolated case reports of potentiating the anticoagulant effect of warfarin, leading to unexpectedly high INR readings
The analysis utilized data from the LEADER and SUSTAIN 6 cardiovascular outcome trials
Veronica, the owner, has been very helpful and the services have helped us a lot
US$ 22.78
US$ 23.64
US$ 20.38
US$ 20.52
